Showing 1 - 2 results of 2 for search 'A. Makiyama', query time: 0.01s Refine Results
  1. 1
    T-cell invigoration to cell-free DNA ratio associated with anti-PD-1 response in gastric or gastro-esophageal junction adenocarcinoma: VOYAGER trial

    T-cell invigoration to cell-free DNA ratio associated with anti-PD-1 response in gastric or gastro-esophageal junction adenocarcinoma: VOYAGER trial by A. Makiyama, Q. Hu, T. Nagasaka, H. Katsuya, A. Nishioka, I. Yasufuku, T. Kashiwada, Y. Shinohara, S. Otsu, M. Shimokawa, H. Saeki, H. Baba, E. Oki

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study

    Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study by K. Nakanishi, N. Sugimoto, Y. Kodera, H. Kawakami, A. Makiyama, H. Konishi, S. Morita, Y. Narita, K. Minashi, M. Imano, R. Inamoto, T. Nishina, T. Kawakami, M. Hagiwara, H. Kume, K. Yamaguchi, W. Hashimoto, K. Muro

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: